Protagonist Therapeutics Inc. (NASDAQ:PTGX)

There are currently no videos for this stock.
To request coverage of this stock, please click the green request video box on the right.
Bands Volume 200 SMA 50 SMA 20 SMA Videos Alerts Articles Events
PTGX Weekly Chart

Old Forum Content for PTGX

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
Loading...
  • traderbren: #Weekly - some weekly charts to keep an eye on: $PTGX, $RCL, $ARGX, $WMT, $AVGO, $MDB, $ON, $WEN, $DT, $EDU, $FIX, $PCAR, $SWAV, $HEIA
  • sierramp: @BarryC Nice BO on $PTGX after ER. Not sure I'm reading the report correctly but appears that Rusfertide Pacific has "multi billion dollar potential in rare hematology diseases". 52 week study completion by Q2 2023. Partnered with Janssen on PN-235 clinical studies. They state: Strong cash position with cash runway through the end of 2025.
  • BarryC: @sierramp $PTGX Cool!!
  • BarryC: $PTGX Worth Watching, needs volume to be good
  • sierramp: @BarryC $PTGX Did the research. I normally stay away from companies with no rev and a ROE of -49.5% but this is an interesting one, a bit like a lottery ticket. I already have two other lottery tickets in my portfolio but I may just grab a little of this ticket too. Phase 3, $JNJ, FDA Orphan Drug designation and FDA fast track designation, several milestone payments. Sure, why not.
  • woodman: @sierramp $PTGX $JNJ - No opinion on PTGX, but if you're interested in biotech investing, then you're going to be looking at companies with no revenue, unless you limit yourself to biotechs with at least one approved product.
  • BarryC: @BarryC $PTGX Im so sorry, I should have been more specific... and you're 100% correct, VERY SPECULATIVE!! I was only referring to a potential push higher for a trade. My bad, I'll be more specific in the future.
  • sierramp: @woodman $PTGX $JNJ Very true. I do have a big chuck of $ARDX as you know. That's another very interesting story. Watching the clock for the upcoming webcast on that one.
  • sierramp: @BarryC $PTGX No need to apologize for anything at all. We are all grownups here and know how to do research. We are all responsible for our own trades. You provided an idea and broke up my morning boredom of waiting for the Fed axe to fall. Thank you.
  • woodman: @sierramp $PTGX $JNJ $ARDX - Do you have a link for the webcast? I've only seen the phone call in number listed in their presser.
  • sierramp: @woodman $PTGX $JNJ $ARDX Sorry, just saw this. I signed in, sounds like it's a web version of the phone call: https://ir.ardelyx.com/events/event-details/ardelyx-q1-2023-earnings-call
  • sierramp: @woodman $PTGX $JNJ This website is doing weird things. A couple of our posts are gone at least on my end. I didn't receive notification of your post but refreshed and checked to find your question about the webcast. I posted the webcast address but it's now not showing on my end. It sounds like it's a web version of the earnings call: https://ir.ardelyx.com/events/event-details/ardelyx-q1-2023-earnings-call
  • BarryC: $PTGX Worth Watching... SPECULATIVE
  • Sher: $PTGX (39.26 +16.02%): Reaches new record highs after announcing updated results from its ongoing Phase 2 study of Rusfertide, under evaluation for the treatment of polycythemia vera; among reported results, therapeutic phlebotomies were essentially eliminated, and a targeted hematocrit of less than 45% was maintained for the vast majority of patients treated with Rusfertide. Just noticed this one - Today's vol. under 700,000 (one month average, 343K) - Shares outstanding, 43.9M... 106% held by institutions - Watching...
  • steve71: @Sher $PTGX Updated results from their ongoing P2 data reported six months ago. A good long term hold but I am not adding on this bump. Might even sell a few. Still a long ways from an FDA decision.
  • lostsheep: $TCS $CRTO $PTGX $REZI $CREE $WIT some ready or in the process of bo $GPC $HAIN $TMUS $DG tightening If mentioned by others I apologize. Not lookingb to steal anyone's thunder @YULS mentioned $EW which looks good.
  • Yuls: @lostsheep $TCS $CRTO $PTGX $REZI $CREE $WIT $GPC $HAIN $TMUS $DG $EW lol no thunders to steal, more people mention same (potentially) good idea, the better, so it gets noticed
  • osgood: @Bridget $CLSD $PTGX has been good, too.
Visit the Trading Forum to join in the discussion.
Stock Price $26.85
Change 0.90%
Volume 333,380

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company with a proprietary peptide-based technology platform focused on discovering and developing new chemical entities to address significant unmet medical needs.

Request Video of PTGX
Already a member? Sign in here.
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 90,400 stock analysis videos
  • Access an ever expanding library (90,400) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!